Bingxing Shi

Title: Innovations by Bingxing Shi

Introduction

Bingxing Shi is a notable inventor based in Beijing, China. He has made significant contributions to the field of medical science, particularly in liver treatment and thrombolytic therapies. With a total of two patents to his name, his work showcases the potential for innovative solutions in healthcare.

Latest Patents

Bingxing Shi's latest patents include "Hepatopoietin and use thereof" and "Bifunctional fusion protein with thrombolytic and anticoagulant activities and uses thereof." The first patent involves a hepatopoietin PCn (HPPCn) and its homologous proteins, which promote hepatocyte proliferation in vitro, enhance liver regeneration in vivo, inhibit tumor cell growth, and induce apoptosis in tumor cells. This innovation holds promise for treating acute and chronic liver injuries, as well as liver fibrosis. The second patent describes a fusion protein composed of a thrombolytic protein, an anticoagulant protein, and a linker peptide. This fusion protein is designed for medical applications, linking proteins that can be recognized and cleaved by blood coagulation factors, thereby enhancing therapeutic efficacy.

Career Highlights

Bingxing Shi is affiliated with the Institute of Radiation Medicine, Academy of Military Medical Sciences, PLA. His work at this prestigious institution has allowed him to focus on groundbreaking research that addresses critical health issues.

Collaborations

Some of his notable coworkers include Zuze Wu and Chunping Cui, who have collaborated with him on various research projects.

Conclusion

Bingxing Shi's innovative patents reflect his commitment to advancing medical science and improving patient outcomes. His contributions are paving the way for new treatments in liver health and thrombolytic therapies.